Valuation (38%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 12.29 | N/A |
PEG Ratio (TTM) | 0.12 | N/A |
P/S Ratio (TTM) | N/A | N/A |
P/B Ratio (TTM) | 1.34 | N/A |
P/FCF Ratio (TTM) | -323.25 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (30%) |
Company | Industry |
---|---|---|
ROA (TTM) | 10.40% | N/A |
ROE (TTM) | 11.20% | N/A |
Net Profit Margin (TTM) | N/A | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 4,278,786,851.85% | N/A | N/A |
Revenue | N/A | N/A | N/A |
Net Income | -38.73% | N/A | N/A |
Cash Flow | -224.67% | N/A | N/A |
Health (21%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.13 | N/A |
Quick Ratio (TTM) | 0.13 | N/A |
D/E Ratio (TTM) | N/A | N/A |
Interest Coverage (TTM) | 0.08 | N/A |
Piotroski F-Score | 2 | N/A |
Altman Z-Score | 7.29 | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |